Breast cancers with EGFR and HER2 co-amplification favor distant metastasis and poor clinical outcome.
Ontology highlight
ABSTRACT: ErbB signaling serves essential roles in invasive ductal carcinoma (IDC). The aim of the present study was to assess gene amplification in ErbB family members in IDC with clinical implications. Quantitative polymerase chain reaction and fluorescence in situ hybridization were performed on formalin-fixed paraffin-embedded tumor samples for gene amplification detection. The clinical and histopathological characteristics, as well as the prognostic significance, were analyzed. Among the 119 IDC patients evaluated, epidermal growth factor receptor [EGFR; also known as human epidermal growth factor receptor (HER)1], HER2, HER3 and HER4 gene amplification was observed in 30 (25.2%), 44 (36.9%), 0 (0.0%) and 1 (0.8%) patients, respectively. EGFR amplificat
SUBMITTER: Guo P
PROVIDER: S-EPMC5696709 | biostudies-literature | 2017 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA